The global point-of-care diagnostics market is expected to grow at a CAGR of 7.2% from 2021 to 2030. The growth in the market is attributed to the increasing prevalence of chronic diseases, rising demand for personalized medicine, and technological advancements in point-of-care diagnostics.
Glucose Monitoring Kits accounted for the largest share of the global point-of-care diagnostics market in 2018 and are expected to continue their dominance throughout the forecast period. Infectious Diseases Testing Kits are projected to be one of the fastest growing segments during this period due to increasing incidence rates of infectious diseases globally. Cardiometabolic Monitoring Kits are also projected to grow at a significant rate during this period due to an increase in awareness about cardiovascular diseases among people across different age groups and regions.
Some Of The Growth Factors Of This Market:
- The growing number of patients with chronic diseases will increase the need for Point-of-Care Diagnostics devices in hospitals and clinics across the globe, which will drive market growth over the next few years.
- Technological advancements in Point-of-Care Diagnostics devices are also expected to fuel market growth during this period as they offer more accurate results than traditional diagnostic methods such as blood tests or X rays that require lab analysis or imaging equipment respectively.
Industry Growth Insights published a new data on “Point-of-Care Diagnostics Market”. The research report is titled “Point-of-Care Diagnostics Market research by Types (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Cardiometabolic Monitoring Kits, Coagulation Monitoring Kits, Hematology Testing Kits, Urinalysis Testing Kits, Cholesterol Test Strips, Drugs-Of-Abuse Testing Kits, Tumor/Cancer Markers, Other), By Applications (Home, Hospitals, Ambulatory Care), By Players/Companies Abbott Laboratories, Abaxis, Alere, Bayer, Danaher Corporation, Becton Dickinson, Johnson & Johnson, Nipro, Roche Diagnostics, Siemens Healthcare, Samsung Medison”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Point-of-Care Diagnostics Market Research Report
By Type
Glucose Monitoring Kits, Infectious Diseases Testing Kits, Cardiometabolic Monitoring Kits, Coagulation Monitoring Kits, Hematology Testing Kits, Urinalysis Testing Kits, Cholesterol Test Strips, Drugs-Of-Abuse Testing Kits, Tumor/Cancer Markers, Other
By Application
Home, Hospitals, Ambulatory Care
By Companies
Abbott Laboratories, Abaxis, Alere, Bayer, Danaher Corporation, Becton Dickinson, Johnson & Johnson, Nipro, Roche Diagnostics, Siemens Healthcare, Samsung Medison
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Point-of-Care Diagnostics Market Report Segments:
The global Point-of-Care Diagnostics market is segmented on the basis of:
Types
Glucose Monitoring Kits, Infectious Diseases Testing Kits, Cardiometabolic Monitoring Kits, Coagulation Monitoring Kits, Hematology Testing Kits, Urinalysis Testing Kits, Cholesterol Test Strips, Drugs-Of-Abuse Testing Kits, Tumor/Cancer Markers, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Home, Hospitals, Ambulatory Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Abaxis
- Alere
- Bayer
- Danaher Corporation
- Becton Dickinson
- Johnson & Johnson
- Nipro
- Roche Diagnostics
- Siemens Healthcare
- Samsung Medison
Highlights of The Point-of-Care Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glucose Monitoring Kits
- Infectious Diseases Testing Kits
- Cardiometabolic Monitoring Kits
- Coagulation Monitoring Kits
- Hematology Testing Kits
- Urinalysis Testing Kits
- Cholesterol Test Strips
- Drugs-Of-Abuse Testing Kits
- Tumor/Cancer Markers
- Other
- By Application:
- Home
- Hospitals
- Ambulatory Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Point-of-Care Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Point-of-care diagnostics is a term used to describe diagnostic tests that are performed by healthcare professionals in the field, such as physicians and nurses. These tests are often used to diagnose diseases or injuries quickly and easily, without having to take the patient into a hospital or clinic.
Some of the major players in the point-of-care diagnostics market are Abbott Laboratories, Abaxis, Alere, Bayer, Danaher Corporation, Becton Dickinson, Johnson & Johnson, Nipro, Roche Diagnostics, Siemens Healthcare, Samsung Medison.
The point-of-care diagnostics market is expected to grow at a compound annual growth rate of 7.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Point-of-Care Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Point-of-Care Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Point-of-Care Diagnostics Market - Supply Chain
4.5. Global Point-of-Care Diagnostics Market Forecast
4.5.1. Point-of-Care Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Point-of-Care Diagnostics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Point-of-Care Diagnostics Market Absolute $ Opportunity
5. Global Point-of-Care Diagnostics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Point-of-Care Diagnostics Market Size and Volume Forecast by Type
5.3.1. Glucose Monitoring Kits
5.3.2. Infectious Diseases Testing Kits
5.3.3. Cardiometabolic Monitoring Kits
5.3.4. Coagulation Monitoring Kits
5.3.5. Hematology Testing Kits
5.3.6. Urinalysis Testing Kits
5.3.7. Cholesterol Test Strips
5.3.8. Drugs-Of-Abuse Testing Kits
5.3.9. Tumor/Cancer Markers
5.3.10. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Point-of-Care Diagnostics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Point-of-Care Diagnostics Market Size and Volume Forecast by Application
6.3.1. Home
6.3.2. Hospitals
6.3.3. Ambulatory Care
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Point-of-Care Diagnostics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Point-of-Care Diagnostics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Point-of-Care Diagnostics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Point-of-Care Diagnostics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Point-of-Care Diagnostics Demand Share Forecast, 2019-2026
9. North America Point-of-Care Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Point-of-Care Diagnostics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Point-of-Care Diagnostics Market Size and Volume Forecast by Application
9.4.1. Home
9.4.2. Hospitals
9.4.3. Ambulatory Care
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Point-of-Care Diagnostics Market Size and Volume Forecast by Type
9.7.1. Glucose Monitoring Kits
9.7.2. Infectious Diseases Testing Kits
9.7.3. Cardiometabolic Monitoring Kits
9.7.4. Coagulation Monitoring Kits
9.7.5. Hematology Testing Kits
9.7.6. Urinalysis Testing Kits
9.7.7. Cholesterol Test Strips
9.7.8. Drugs-Of-Abuse Testing Kits
9.7.9. Tumor/Cancer Markers
9.7.10. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Point-of-Care Diagnostics Demand Share Forecast, 2019-2026
10. Latin America Point-of-Care Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Point-of-Care Diagnostics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Point-of-Care Diagnostics Market Size and Volume Forecast by Application
10.4.1. Home
10.4.2. Hospitals
10.4.3. Ambulatory Care
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Point-of-Care Diagnostics Market Size and Volume Forecast by Type
10.7.1. Glucose Monitoring Kits
10.7.2. Infectious Diseases Testing Kits
10.7.3. Cardiometabolic Monitoring Kits
10.7.4. Coagulation Monitoring Kits
10.7.5. Hematology Testing Kits
10.7.6. Urinalysis Testing Kits
10.7.7. Cholesterol Test Strips
10.7.8. Drugs-Of-Abuse Testing Kits
10.7.9. Tumor/Cancer Markers
10.7.10. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Point-of-Care Diagnostics Demand Share Forecast, 2019-2026
11. Europe Point-of-Care Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Point-of-Care Diagnostics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Point-of-Care Diagnostics Market Size and Volume Forecast by Application
11.4.1. Home
11.4.2. Hospitals
11.4.3. Ambulatory Care
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Point-of-Care Diagnostics Market Size and Volume Forecast by Type
11.7.1. Glucose Monitoring Kits
11.7.2. Infectious Diseases Testing Kits
11.7.3. Cardiometabolic Monitoring Kits
11.7.4. Coagulation Monitoring Kits
11.7.5. Hematology Testing Kits
11.7.6. Urinalysis Testing Kits
11.7.7. Cholesterol Test Strips
11.7.8. Drugs-Of-Abuse Testing Kits
11.7.9. Tumor/Cancer Markers
11.7.10. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Point-of-Care Diagnostics Demand Share, 2019-2026
12. Asia Pacific Point-of-Care Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Point-of-Care Diagnostics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Point-of-Care Diagnostics Market Size and Volume Forecast by Application
12.4.1. Home
12.4.2. Hospitals
12.4.3. Ambulatory Care
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Point-of-Care Diagnostics Market Size and Volume Forecast by Type
12.7.1. Glucose Monitoring Kits
12.7.2. Infectious Diseases Testing Kits
12.7.3. Cardiometabolic Monitoring Kits
12.7.4. Coagulation Monitoring Kits
12.7.5. Hematology Testing Kits
12.7.6. Urinalysis Testing Kits
12.7.7. Cholesterol Test Strips
12.7.8. Drugs-Of-Abuse Testing Kits
12.7.9. Tumor/Cancer Markers
12.7.10. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Point-of-Care Diagnostics Demand Share, 2019-2026
13. Middle East & Africa Point-of-Care Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Point-of-Care Diagnostics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Point-of-Care Diagnostics Market Size and Volume Forecast by Application
13.4.1. Home
13.4.2. Hospitals
13.4.3. Ambulatory Care
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Point-of-Care Diagnostics Market Size and Volume Forecast by Type
13.7.1. Glucose Monitoring Kits
13.7.2. Infectious Diseases Testing Kits
13.7.3. Cardiometabolic Monitoring Kits
13.7.4. Coagulation Monitoring Kits
13.7.5. Hematology Testing Kits
13.7.6. Urinalysis Testing Kits
13.7.7. Cholesterol Test Strips
13.7.8. Drugs-Of-Abuse Testing Kits
13.7.9. Tumor/Cancer Markers
13.7.10. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Point-of-Care Diagnostics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Point-of-Care Diagnostics Market: Market Share Analysis
14.2. Point-of-Care Diagnostics Distributors and Customers
14.3. Point-of-Care Diagnostics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abaxis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Alere
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Danaher Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Becton Dickinson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Johnson & Johnson
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Nipro
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Roche Diagnostics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Siemens Healthcare
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Samsung Medison
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
